| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,126 | 783 | 12,039 | 9,815 | | Cost of Revenue | 2,369 | 166 | 8,890 | 8,115 | | | Gross Profit | (11,179) | 617 | 3,149 | 1,700 | | | Operating Expenses | | Research Development | 1,452 | 171 | 2,840 | 3,163 | | Selling General and Administrative | 1,968 | 1,472 | 2,821 | 3,547 | | Non Recurring | (21) | (16) | 1,249 | 6,161 | | Others |
-
|
-
|
-
| 179 | | | | Total Operating Expenses |
-
|
-
|
-
| 13,050 | | | | Operating Income or Loss | (2,413) | (1,010) | (3,761) | (11,350) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 107 | 93 | 206 | | Earnings Before Interest And Taxes | (2,645) | (903) | (3,668) | (11,144) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (2,645) | (903) | (3,668) | (11,144) | | Income Tax Expense | (11) | (13) | (8) | (88) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,634) | (890) | (3,660) | (11,056) | | | Non-recurring Events | | Discontinued Operations | 41 | 17,530 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,593) | 16,640 | (3,660) | (11,056) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,593) | $16,640 | ($3,660) | ($11,056) |
|
0.11% Nasdaq 
0.01%
Income Statement
